New Deal
Mark Lampert
Founder and CEO at BVF PARTNERS
Investor
Deal Bio
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.
Expertise (12)
Key Relationships
Sort
Miragen Therapeutics
VENROCK
£70m
19 dealmakers
Ikena Oncology
Omega Funds
£88m
15 dealmakers
Day One Biopharmaceuticals
Ra Capital Management
£94m
11 dealmakers
Centessa Pharmaceuticals
Janus Henderson Investors
£179m
27 dealmakers
EQRX
Bvf Partners
£2,622m
53 dealmakers
Cincor Pharma
£104m
SHOUTI
Casdin Capital
£72m
20 dealmakers
Moonlake Immunotherapeutics
£169m
44 dealmakers
Ventus Therapeutics
Andreessen Horowitz
£103m
12 dealmakers
ELEKTROFI
£32m
10 dealmakers
SEPTERNA
£116m
Crossbow Therapeutics
Mirae Asset Venture Investment
£62m
9 dealmakers
Boost your presence by claiming deals. Enhance your profile, highlighting your industry impact.